Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of combination of INCB99280 and RP1 in patients with cutaneous squamous cell carcinoma

Trial Profile

A study of combination of INCB99280 and RP1 in patients with cutaneous squamous cell carcinoma

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 03 Aug 2023 New trial record
  • 31 Jul 2023 According to a Replimune media release, the company has entered into a clinical trial collaboration and supply agreement with Incyte to study RP1 and INCB99280 combination in patients with Cutaneous Squamous Cell Carcinoma. Under the terms of the agreement, Incyte will initiate and sponsor the clinical trial with the clinical trial expected to initiate in early 2024. Replimune will supply Incyte with RP1 for the study and share equally in the costs of the study.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top